Media mentions

<p>Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.</p>
29 Nov 2019

The most common breast cancer under siege

The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells.

<p>Meritxell Teixidó, IRB Barcelona</p>
27 Nov 2019

How to get drugs into the brain?

In its “Preguntas Big Van” section, the newspaper La Vanguardia has interviewed IRB Barcelona researcher Meritxell Teixidó about her project, which seeks to develop “shuttles” that transport drugs into the brain.

<p>Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.</p>
27 Nov 2019

Immunotherapy paves the way beyond cancer

The newspapers El País and ABC, among other media, have echoed on the last Barcelona Biomed Conference, called “Immunotherapy beyond cancer.

Contact

Office of Communications and External Relations
Tel: +34 93 40 34569

Basic information about IRB

Quick facts

IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.